Lightship vs Tempus

Side-by-side comparison of AI visibility scores, market position, and capabilities

Tempus leads in AI visibility (74 vs 34)
Lightship logo

Lightship

EmergingLife Sciences & BioTech

Decentralized & Hybrid Clinical Trial Services

Lightship is a clinical research organization (CRO) specializing in decentralized and hybrid clinical trial design, combining in-clinic visits, at-home appointments, mobile research units, and digital health tools to improve participant access and.

AI VisibilityBeta
Overall Score
D34
Category Rank
#182 of 198
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
34
Perplexity
37
Gemini
29

About

Lightship is a clinical research organization (CRO) founded with the mission of reimagining how clinical trials are designed and conducted to dramatically improve participant access and health equity. Traditional clinical research requires participants to travel to major academic medical centers or specialized research sites for frequent, often burdensome in-clinic visits — a model that systematically excludes working adults, rural populations, elderly patients, and underrepresented communities. Lightship designs and executes studies using a spectrum of participation modalities: traditional in-clinic visits, at-home appointments with study nurses who travel to participants, mobile research units that bring clinical procedures to community locations, and digital health tools that enable remote data collection between visits.

Full profile
Tempus logo

Tempus

LeaderLife Sciences & BioTech

AI-Enabled Precision Medicine

Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.

AI VisibilityBeta
Overall Score
B74
Category Rank
#11 of 198
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
71
Perplexity
68
Gemini
80

About

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.

Full profile

AI Visibility Head-to-Head

34
Overall Score
74
#182
Category Rank
#11
78
AI Consensus
68
stable
Trend
stable
34
ChatGPT
71
37
Perplexity
68
29
Gemini
80
30
Claude
77
29
Grok
69

Key Details

Category
Decentralized & Hybrid Clinical Trial Services
AI-Enabled Precision Medicine
Tier
Emerging
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.